Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inter-batch consistency trial of three consecutive batches of live attenuated varicella vaccine in healthy children
ChiCTR2400091380Phase 4Completed
- Sponsor
- Hubei Provincial Center for Disease Control and Prevention
- Start
- Oct 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of varicella vaccine live in chickenpox (9 arms), sponsored by Hubei Provincial Center for Disease Control and Prevention. Primary endpoint: Anti-VZV antibody geometric mean titer. Started Oct 2024; status: completed.
02
Drugs
varicella vaccine live
03
Conditions
chickenpox
Beyond the preview
Go deeper on ChiCTR2400091380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091380.